Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
CGC · Nasdaq · United States · Medicinal Chemicals & Botanical Products
In shortCanopy Growth Corp is loss-making, burns cash and holds more cash than debt, with revenue growing (+10.5% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -46.6% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -75.8% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -44.7% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -13.7% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 3.34× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.33× | 93/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -4.23× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -29.51 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -19.9% | 0/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 0 of 5 | 0/100 |
Weight in the score: 20%
| Profitable years (last 5) | 0 of 5 | 0/100 |
|---|---|---|
| Years of revenue decline (last 5) | 4 of 5 | 0/100 |
| Revenue growth volatility | 14.0% | 59/100 |
| Operating margin volatility | 277.4% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -3.1% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2026 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
4 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
CAD millions; negative values in parentheses.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 538 | 381 | 344 | 314 | 347 |
| Cost of revenue | 663 | 397 | 216 | 189 | 215 |
| Gross profit | (187) | (64) | 81 | 80 | 70 |
| Research & development | 32 | 22 | 4.6 | 2.7 | 2.6 |
| Selling, general & admin | 415 | 343 | 229 | 170 | 160 |
| Operating income | (1,019) | (2,631) | (229) | (117) | (162) |
| Interest expense | 104 | 126 | 105 | 75 | 38 |
| Pre-tax income | (268) | (3,086) | (508) | (508) | (263) |
| Income tax | (8.9) | (5.7) | 12 | 7.1 | 0 |
| Net income | (310) | (3,278) | (694) | (509) | (263) |
| Diluted EPS | −C$7.92 | −C$70.69 | −C$9.27 | −C$4.73 | −C$0.88 |
| Diluted shares (millions) | 39 | 46 | 75 | 108 | 298 |
4 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in CAD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of Canopy Growth Corp are included in the Investor plan. Try free for 7 days →
−29.51 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 7, 2026